McMAHON et al., 1986 - Google Patents
Interferon-induced gene expression in wild-type and interferon-resistant human lymphoblastoid (Daudi) cellsMcMAHON et al., 1986
View PDF- Document ID
- 7411611587595054459
- Author
- McMAHON M
- Stark G
- Kerr I
- Publication year
- Publication venue
- Journal of virology
External Links
Snippet
Interferon-induced gene expression was analyzed in wild-type and interferon-resistant Daudi cells. Two classes of alpha-interferon-induced mRNAs and proteins were observed: those that were similarly induced in both types of cell and those that were induced only in …
- 102000014150 Interferons 0 title abstract description 31
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
- C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McMAHON et al. | Interferon-induced gene expression in wild-type and interferon-resistant human lymphoblastoid (Daudi) cells | |
| Sen | Mechanism of interferon action: progress toward its understanding | |
| Brown et al. | Poly (C) in animal viral RNAs | |
| Setzer et al. | Size heterogeneity in the 3′ end of dihydrofolate reductase messenger RNAs in mouse cells | |
| Larner et al. | Transcriptional induction of two genes in human cells by beta interferon. | |
| Hijikata et al. | Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt–88) correlated with the response of hepatitis C patients to interferon | |
| Cowan et al. | Expression of human α-tubulin genes: interspecies conservation of 3′ untranslated regions | |
| McMahon et al. | Identification of an activated c-Ki-ras oncogene in rat liver tumors induced by aflatoxin B1. | |
| Moribe et al. | Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy | |
| Garman et al. | Alterations in cell surface membranes in Chinese hamster lung cells resistant to adriamycin | |
| Hijikata et al. | Genetic polymorphism of the MxA gene promoter and interferon responsiveness of hepatitis C patients: revisited by analyzing two SNP sites (–123 and–88) in vivo and in vitro | |
| Oberman et al. | Inhibition of transcription of herpes simplex virus immediate early genes in interferon-treated human cells | |
| Hay et al. | Influenza virus messenger RNAs are incomplete transcripts of the genome RNAs | |
| Wengler et al. | Localization of the 26-S RNA sequence on the viral genome type 42-S RNA isolated from SFV-infected cells | |
| Soler et al. | Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment | |
| Shaila et al. | Characteristics of extracts from interferon-treated HeLa cells: presence of a protein kinase and endoribonuclease activated by double-stranded RNA and of an inhibitor of mRNA methylation | |
| Giantini et al. | Reovirus type 3 genome segment S4: nucleotide sequence of the gene encoding a major virion surface protein | |
| Pozzato et al. | Interferon therapy in chronic hepatitis C virus: evidence of different outcome with respect to different viral strains | |
| Khabar et al. | Expressed gene clusters associated with cellular sensitivity and resistance towards anti-viral and anti-proliferative actions of interferon | |
| LEE et al. | Interferon-α2 variants in the human genome | |
| Dron et al. | Interferon modulation of c-myc expression in cloned Daudi cells: relationship to the phenotype of interferon resistance | |
| Lu et al. | Analysis of hepatitis C virus quasispecies populations by temperature gradient gel electrophoresis | |
| Radsak et al. | Effect of 2-deoxy-D-glucose on cytomegalovirus-induced DNA synthesis in human fibroblasts | |
| Huber et al. | Studies of gene transcription and translation in regenerating rat liver | |
| Hardy et al. | Immunological properties of fractionated avian erythroid nuclei |